Search

everythinglearnresearchcommunity

for

Search:↓

PRGF treatments increased hair number and thickness in people with hair loss, with more injections leading to better results.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Most men stopped using the hair loss treatment not because of sexual side effects, but because they didn't see positive results.

Botulinum toxin injections can help treat common hair loss in men, but more research is needed to confirm this and understand how it works.

Botulinum toxin may be helpful for treating male pattern baldness.

Platelet-rich plasma injections effectively treat hair loss in both men and women, increasing hair density with high patient satisfaction and no significant side effects.

Finasteride gel and tablet both have similar moderate effects in treating male hair loss.

More research is needed to understand how skin type affects laser treatment for hair loss.

Platelet-rich plasma injections can effectively treat male pattern hair loss, improving hair density and quality with high patient satisfaction.

Men with early-onset hair loss have more heart disease risk factors.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Dutasteride is more effective than finasteride for long-term hair growth in men with androgenic alopecia.

Severe and early hair loss may indicate a higher risk of heart disease.

PRP injections can increase hair density in people with androgenic alopecia.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Microneedling combined with other treatments significantly improves hair growth in people with hair loss and is safe.

Sinclair grading effectively identifies female androgenic alopecia patterns, with Grade III most common.

Many men with androgenic alopecia also have dyslipidemia.

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.

There's a significant link between severe hair loss and metabolic syndrome in Saudi Arabia, suggesting early health checks could prevent future issues.

PRP is an effective and safe treatment for hair loss.

Men with early-onset hair loss have a higher risk of metabolic syndrome.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Mesotherapy is not significantly better than minoxidil for treating male hair loss.